ArticleActa pharmaceutica Sinica. B2022

Characterization of a novel bispecific antibody targeting tissue factor-positive tumors with T cell engagement.

Zhidi Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.